Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Endovascular Exclusion of Ascending and Thoracic Aortic Pathology

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2017 by The Cleveland Clinic
The Cleveland Clinic
Information provided by (Responsible Party):
Matthew Eagleton, The Cleveland Clinic Identifier:
First received: December 20, 2007
Last updated: April 12, 2017
Last verified: April 2017
The purpose of this study is to assess the role of ascending and/or aortic arch aneurysm/dissections treatment using a novel endovascular prosthesis in high risk surgical patients.

Condition Intervention
Thoracic Aortic Aneurysms
Dissecting, Aneurysm
Ascending Aorta Aneurysm
Aortic Arch; Aneurysm, Dissecting
Ascending Aortic Dissection
Device: Endovascular stent-graft implantation

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: No masking
Primary Purpose: Treatment
Official Title: Endovascular Exclusion of Ascending and Thoracic Aortic Pathology

Resource links provided by NLM:

Further study details as provided by The Cleveland Clinic:

Primary Outcome Measures:
  • Freedom from aneurysm rupture [ Time Frame: 2 years ]
    Absence of blood extravasation outside of aneurysm sac demonstrated by CT scan

Estimated Enrollment: 35
Study Start Date: May 2001
Estimated Study Completion Date: December 2020
Estimated Primary Completion Date: December 2020 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Ascending Aortic Arm
Investigational endovascular stent-graft implantation to exclude aneurysm or repair dissection of the ascending aorta.
Device: Endovascular stent-graft implantation
Endovascular repair with a research device
Other Name: Cook Zenith
Experimental: Arch Branch Arm
Investigational endovascular stent-graft implantation to exclude aneurysm or repair dissection of the aortic arch.
Device: Endovascular stent-graft implantation
Endovascular repair with a research device
Other Name: Cook Zenith

Detailed Description:
This study is a prospective, non-randomized evaluation of ascending and thoracic pathology endovascular repair in the high-risk patient. The purpose of this study is to assess the role of the thoracic aortic pathology treatment using endovascular prosthesis in high-risk patients. The study objectives include (1) to assess the safety and efficacy of endovascular prosthesis as a means of preventing aneurysm growth and rupture in high risk patients, (2) to measure the physiologic effects and outcomes of endovascular aneurysm repair, (3) to establish selection criteria, improve device design, operative technique, and follow-up procedures for patients undergoing aneurysm repair. There will be up to 15 patients in the ascending aortic lesion arm and 20 patients in Arch Branch arm; all at one site (The Cleveland Clinic). Baseline procedures may include an angiogram, intravascular ultrasound, CT scan, chest x-ray, physical exam, blood work, and ankle-brachial index. The endovascular prosthesis is placed in the operating room under regional or general anesthesia. Follow-up evaluations may include physical exam, blood work, CT scan or MRI, chest x-ray, cardiac echo and ankle-brachial index.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

i)Life expectancy greater than 2 years ii) Suitable arterial anatomy iii) Absence of systemic disease or allergy that precludes an endovascular repair iv) Capable of giving informed consent and willingness to comply with follow up schedule v) Patient is considered high or prohibitive risk for open surgical repair of the ascending aneurysm or dissection

Exclusion Criteria:

Patient excluded if ANY of the following are true:

i) Pregnancy ii) History of anaphylactic reaction to contrast material with an inability to properly prophylax the patient appropriately iii) Allergy to stainless steel or polyester (allergy to stainless steel is not relevant if the Low Profile device is to be used) iv) Unwilling to comply with follow up schedule v) Serious or systemic groin infection vi) An uncorrectable coagulopathy

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00583817

Contact: Yuki Kuramochi, RN, BSN 216-445-4063

United States, Ohio
Cleveland Clinic Recruiting
Cleveland, Ohio, United States, 44195
Principal Investigator: Matthew Eagleton, MD         
Sub-Investigator: Eric Roselli, MD         
Sub-Investigator: Federico E Parodi, MD         
Sponsors and Collaborators
Matthew Eagleton
The Cleveland Clinic
Principal Investigator: Matthew J Eagleton, MD The Cleveland Clinic
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Matthew Eagleton, Staff, The Cleveland Clinic Identifier: NCT00583817     History of Changes
Other Study ID Numbers: G000101
IRB 3917 ( Other Identifier: Cleveland Clinic IRB )
Study First Received: December 20, 2007
Last Updated: April 12, 2017
Individual Participant Data  
Plan to Share IPD: No

Additional relevant MeSH terms:
Aortic Aneurysm
Aortic Aneurysm, Thoracic
Aneurysm, Dissecting
Vascular Diseases
Cardiovascular Diseases
Aortic Diseases processed this record on May 22, 2017